Deutsche Tageszeitung - Cameroon launches historic large-scale malaria jab campaign

Cameroon launches historic large-scale malaria jab campaign


Cameroon launches historic large-scale malaria jab campaign
Cameroon launches historic large-scale malaria jab campaign / Photo: © AFP/File

Cameroon on Monday launched the first malaria vaccination programme to be offered nationwide and as a matter of routine, AFP journalists saw, in a step the WHO has described as "historic".

Change text size:

The mosquito-borne disease kills more than 600,000 people a year, mainly in Africa, according to the World Health Organization.

Children under five years old account for more than 80 percent of deaths on the continent.

Following a pilot phase, the RTS,S vaccine is being rolled out at scale across Africa, starting in Cameroon.

At a hospital in the town of Soa, 20 kilometres (12 miles) from the capital Yaounde, six-month-old Noah Ngah became the first to receive the injection at the facility.

Cheered and encouraged by the nurses, the infant received the jab -- much to the relief of his mother, who was waiting to have his twin sister vaccinated too.

"Some parents are reticent but I know that vaccines are good for children," their mother Helene Akono told AFP.

It is one of many vaccine centres in 42 districts designated a priority across the vast central African nation of some 28 million people.

The jab will be offered free of charge, according to the government, and systematically to all children under six months old at the same time as other obligatory or recommended vaccinations.

The WHO, the UN children's agency UNICEF and the Gavi vaccine alliance said in November that the move was "a historic step towards broader vaccination against one of the deadliest diseases for African children".

- Saving lives -

More than 300,000 doses of RTS,S -- the first malaria vaccine recommended by the UN's WHO -- arrived in Yaounde in late November.

It took two months to organise Monday's launch.

Since 2019, more than two million children have been jabbed in Ghana, Kenya and Malawi in a pilot phase.

The drive resulted in substantial reductions in severe malaria illness and hospitalisations.

Cameroon is the first large-scale and systematic programme in the world, according to the WHO, the coordinator of the campaign which is largely financed by Gavi.

"In Cameroon, 30 percent of consultations are linked to malaria," Aurelia Nguyen, chief programme officer of the Gavi vaccine alliance, told AFP.

"Having a preventative tool like the vaccine will free up the health system and result in fewer hospitalisations and deaths."

Burkina Faso, Liberia, Niger and Sierra Leone are set to follow with large-scale vaccination programmes.

Willis Akhwale, special adviser at End Malaria Council Kenya, said the rollout was a relief but not a "silver bullet".

"The efficacy, much as it is saving lives, is not 100 percent, but even at 40 percent it's saving lives and especially at the age bracket of two years old when you tend to get severe malaria," he told AFP.

(L.Møller--DTZ)

Featured

RCSI President Calls for Enhanced Surgical Research Support at Millin Meeting

Professor Michael Kerin, president of the Royal College of Surgeons in Ireland (RCSI), has called for increased support for surgeons to strengthen the nation's surgical research capacity. His remarks preceded the annual Millin Meeting, a gathering of leading healthcare experts focused on integrating innovation and clinical trials into everyday surgical practice.

Toddler Diagnosed With Leukemia After Symptoms Dismissed as Winter Illness

Manraj Singh Hans, now seven, was diagnosed with acute lymphoblastic leukemia in February 2023 after a prolonged period during which his early symptoms were repeatedly misdiagnosed as common infections. His parents, Narinder Singh and Parm Hans, initially dismissed signs of illness as winter fatigue before blood in the child’s diaper prompted urgent medical intervention.

American Airlines passenger falls ill and vomits on three travellers

A passenger on board an American Airlines reportedly experienced a medical episode mid-flight A morning flight from Philadelphia to Miami was thrown into disarray after a passenger reportedly vomited over three other travellers.

iPS Cell Research Accelerates Drug Discovery for ALS and Spinal Cord Injury

Researchers at Keiō University are leveraging induced pluripotent stem (iPS) cells to accelerate drug discovery for rare neurological conditions. Director Okano Hideyuki reports that human-derived cell models have enabled the rapid identification of potential treatments for amyotrophic lateral sclerosis and paved the way for regenerative therapies targeting spinal cord injuries.

Change text size: